Preben Bruun-Nyzell

Preben Bruun-Nyzell

Preben is 2N Pharma’s co-founder and CEO and brings broad business and finance experience from an international career spanning nine countries over 25 years. He is co-founder of clinical-stage vaccine company 2A Pharma, and chairman of Apoglyx, a Swedish biotech...
John Nieland, PhD

John Nieland, PhD

John is 2N Pharma’s co-founder and CSO and brings broad management experience and a strong scientific background. He was previously director of research at Medigene AG. Next, he is co-founder of the clinical-stage vaccine company 2A Pharma. In addition to...
Alasdair Naylor, PhD

Alasdair Naylor, PhD

Alasdair Naylor is a pharmacologist with over 30 years of experience. He gained his expertise at Pfizer and Solace Pharmaceuticals. More, he is the founder of a new start-up pain company, Sevenless Therapeutics. In addition to holding senior positions in these...
Gavin Kilpatrick, PhD

Gavin Kilpatrick, PhD

Gavin Kilpatrick Ph.D. is a pharmacologist with over 30 years of experience in the biotechnology and pharmaceutical sectors. He has held senior management positions at GSK, CeNeS, Paion, Roche, and Takeda. Moreover, he was a founder of the biotechnology company...
Anne Skøttrup Mørkholt, PhD

Anne Skøttrup Mørkholt, PhD

Anne completed her doctorate at the Laboratory of Metabolism Modifying Medicine, Aalborg University. She researched the connection between dysfunction of the lipid metabolism and CNS diseases, including multiple sclerosis and depression.
Steinunn Sara Helgudóttir, PhD

Steinunn Sara Helgudóttir, PhD

Steinunn completed her doctorate at the Neurobiology Research and Drug Delivery Group at Aalborg University. She conducted research on targeted drug delivery through the blood-brain barrier.